Pharsight

Drug Patents owned by Alcon Labs Inc

1. List of Pataday Once Daily Relief drug patents

PATADAY ONCE DAILY RELIEF Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8791154 ALCON LABS INC High concentration olopatadine ophthalmic composition
May, 2032

(9 years from now)

US9533053 ALCON LABS INC High concentration olopatadine ophthalmic composition
May, 2032

(9 years from now)

Drugs and Companies using OLOPATADINE HYDROCHLORIDE ingredient

Market Authorisation Date: 30 January, 2015

Treatment: Treatment of ocular itching associated with allergic conjunctivitis

Dosage: SOLUTION/DROPS;OPHTHALMIC

How can I launch a generic of PATADAY ONCE DAILY RELIEF before it's patent expiration?
More Information on Dosage

PATADAY ONCE DAILY RELIEF family patents

6

United States

4

Korea, Republic of

2

China

2

European Union

1

South Africa

1

Mexico

1

Australia

1

Hong Kong

1

Russia

1

Uruguay

1

Argentina

1

Colombia

1

Brazil

1

Spain

1

Chile

1

Taiwan, Province of China

1

Ukraine

1

Japan

1

Canada

2. List of Simbrinza drug patents

SIMBRINZA's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9421265 ALCON LABS INC Aqueous pharmaceutical compositions containing borate-polyol complexes
Jun, 2030

(7 years from now)

US9044484 ALCON LABS INC Aqueous pharmaceutical compositions containing borate-polyol complexes
Oct, 2030

(7 years from now)

Drugs and Companies using BRIMONIDINE TARTRATE; BRINZOLAMIDE ingredient

Market Authorisation Date: 19 April, 2013

Treatment: NA

Dosage: SUSPENSION/DROPS;OPHTHALMIC

How can I launch a generic of SIMBRINZA before it's patent expiration?
More Information on Dosage

SIMBRINZA family patents

5

United States

4

European Union

3

Denmark

3

Slovenia

3

Portugal

3

Spain

3

Poland

3

Japan

2

Hong Kong

2

Hungary

2

Argentina

2

Croatia

2

China

1

South Africa

1

Mexico

1

Australia

1

Russia

1

Lithuania

1

Uruguay

1

Brazil

1

Cyprus

1

Korea, Republic of

1

San Marino

1

Chile

1

Taiwan, Province of China

1

Canada

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic